Agios Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 02/14/2025 | 5.67 M | $186.46 M | 0.24% | 9.97% |
| VANGUARD GROUP INC | 02/11/2025 | 5.63 M | $185.05 M | 1.54% | 9.89% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 5.02 M | $164.83 M | -0.11% | 8.81% |
| BELLEVUE GROUP AG | 02/14/2025 | 3.52 M | $115.51 M | -5.91% | 6.17% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 2.42 M | $79.64 M | -14.44% | 4.26% |
| ARMISTICE CAPITAL, LLC | 02/14/2025 | 2.26 M | $74.41 M | 2.59% | 3.98% |
| STATE STREET CORP | 02/14/2025 | 2.15 M | $70.72 M | -7.68% | 3.78% |
| 02/10/2025 | 2.01 M | $66.43 M | -8.01% | 3.53% | |
| MACQUARIE GROUP LTD | 02/14/2025 | 1.68 M | $55.37 M | -0.34% | 2.96% |
| JEFFERIES FINANCIAL GROUP INC. | 02/27/2025 | 1.50 M | $49.29 M | 100.00% | 2.63% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.35 M | $44.36 M | -0.58% | 2.37% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 1.33 M | $43.67 M | -14.92% | 2.33% |
| BVF INC/IL | 02/14/2025 | 1.07 M | $35.28 M | -9.78% | 1.89% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 1.07 M | $35.15 M | 2.45% | 1.88% |
| JPMORGAN CHASE & CO | 02/12/2025 | 1.02 M | $33.36 M | -40.73% | 1.78% |
| FISHER ASSET MANAGEMENT, LLC | 02/05/2025 | 960,661 | $31.57 M | 12.31% | 1.69% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 02/12/2025 | 942,189 | $30.96 M | 3.87% | 1.65% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 935,252 | $30.73 M | 39.67% | 1.64% |
| ARROWMARK COLORADO HOLDINGS LLC | 02/14/2025 | 917,420 | $30.15 M | 3.93% | 1.61% |
| GW&K INVESTMENT MANAGEMENT, LLC | 02/05/2025 | 683,463 | $22.46 M | 8.32% | 1.20% |
| MARSHALL WACE, LLP | 02/13/2025 | 631,628 | $20.76 M | -50.00% | 1.11% |
| POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 627,036 | $20.60 M | -37.42% | 1.10% |
| CALIGAN PARTNERS LP | 02/14/2025 | 626,280 | $20.58 M | 8.03% | 1.10% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 567,170 | $18.64 M | 18.99% | 1.00% |
| D. E. SHAW & CO., INC. | 02/14/2025 | 516,475 | $16.97 M | -2.99% | 0.91% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 02/12/2025 | 499,134 | $16.40 M | 27.38% | 0.88% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 472,547 | $15.53 M | 1.49% | 0.83% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 471,086 | $15.48 M | -32.64% | 0.83% |
| LOOMIS SAYLES & CO L P | 02/12/2025 | 417,208 | $13.71 M | -31.87% | 0.73% |
| MORGAN STANLEY | 02/14/2025 | 378,089 | $12.42 M | 8.34% | 0.66% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 354,455 | $11.65 M | -11.57% | 0.62% |
| EAGLE HEALTH INVESTMENTS LP | 02/12/2025 | 330,830 | $10.87 M | 0.00% | 0.58% |
| CENTERBOOK PARTNERS LP | 02/13/2025 | 305,599 | $10.04 M | 98.33% | 0.54% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 303,000 | $9.96 M | 100.00% | 0.53% |
| CUTTER CAPITAL MANAGEMENT, LP | 02/14/2025 | 301,623 | $9.91 M | 61.62% | 0.53% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2025 | 276,439 | $9.08 M | 100.00% | 0.49% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 265,514 | $8.72 M | 48.81% | 0.47% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 251,774 | $8.27 M | 8.03% | 0.44% |
| CASDIN CAPITAL, LLC | 02/14/2025 | 250,000 | $8.22 M | 100.00% | 0.44% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 248,038 | $8.15 M | 100.00% | 0.44% |
| UBS GROUP AG | 02/14/2025 | 234,343 | $7.70 M | 105.23% | 0.41% |
| NORDEA INVESTMENT MANAGEMENT AB | 01/06/2025 | 220,569 | $7.19 M | 3.57% | 0.39% |
| JANE STREET GROUP, LLC | 02/14/2025 | 214,027 | $7.03 M | 69.18% | 0.38% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 200,481 | $6.59 M | 2.08% | 0.35% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 199,970 | $6.57 M | 136.88% | 0.35% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 199,538 | $6.56 M | 38.55% | 0.35% |
| CITIGROUP INC | 02/12/2025 | 193,152 | $6.35 M | 168.03% | 0.34% |
| AXA S.A. | 02/14/2025 | 175,377 | $5.76 M | -26.54% | 0.31% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 170,504 | $5.60 M | 787.12% | 0.30% |
| CANDRIAM S.C.A. | 02/07/2025 | 169,550 | $5.57 M | -35.16% | 0.30% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Agios Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 307 institutional investors and hedge funds held shares of Agios Pharmaceuticals, Inc.. The most heavily invested institutionals were:
FARALLON CAPITAL MANAGEMENT LLC: 5.67 M
VANGUARD GROUP INC: 5.63 M
BlackRock Funding, Inc. /DE: 5.02 M
Bellevue Group AG: 3.52 M
PRICE T ROWE ASSOCIATES INC /MD/: 2.42 M
ARMISTICE CAPITAL, LLC: 2.26 M
105.04% of Agios Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 74.60 M shares in the last 24 months. This purchase volume represents approximately $2.36 B in transactions.